Edesa Biotech Inc (EDSA)
4.46
+0.10
(+2.29%)
USD |
NASDAQ |
Apr 19, 16:00
4.46
0.00 (0.00%)
After-Hours: 19:39
Edesa Biotech Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | -402.9K% |
| June 30, 2020 | -1.61K% |
| March 31, 2020 | -1.35K% |
| December 31, 2019 | -1.02K% |
| September 30, 2019 | -232.4% |
| June 30, 2019 | -258.8K% |
| March 31, 2019 | -1.41K% |
| December 31, 2018 | -2.65K% |
| September 30, 2018 | -2.08K% |
| June 30, 2018 | -1.58K% |
| March 31, 2018 | -2.11K% |
| December 31, 2017 | -6.84K% |
| September 30, 2017 | -42.39K% |
| June 30, 2017 | -5.94K% |
| March 31, 2017 | -1.75K% |
| December 31, 2016 | -1.05K% |
| September 30, 2016 | -485.8% |
| June 30, 2016 | -659.4% |
| March 31, 2016 | -263.8% |
| December 31, 2015 | -333.9% |
| September 30, 2015 | -766.2% |
| Date | Value |
|---|---|
| June 30, 2015 | |
| March 31, 2015 | -227.1% |
| December 31, 2014 | -631.7% |
| August 31, 2014 | -3.89K% |
| May 31, 2014 | |
| February 28, 2014 | -261.2% |
| November 30, 2013 | -9.09K% |
| August 31, 2013 | -3.02K% |
| May 31, 2013 | -1.60K% |
| February 28, 2013 | -5.93K% |
| November 30, 2012 | -661.8% |
| August 31, 2012 | -4.15K% |
| May 31, 2012 | -3.25K% |
| February 29, 2012 | -1.93K% |
| November 30, 2011 | -707.2% |
| August 31, 2011 | |
| May 31, 2011 | |
| February 28, 2011 | -561.9% |
| November 30, 2010 | -8.79K% |
| August 31, 2010 | -29.32% |
| May 31, 2010 | -209.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-402.9K%
Minimum
Sep 2020
-232.4%
Maximum
Sep 2019
-111.0K%
Average
-1.48K%
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
| ESSA Pharma Inc | -- |